Market Overview - On June 17, the brain science sector experienced a collective surge, with stocks like Aipeng Medical and Innovation Medical hitting the daily limit, while others like Nanjing Panda and Beilu Pharmaceutical also saw significant gains [1][2]. Industry Developments - Chinese concept stocks in brain regeneration technology surged by 283% in the US market, with a cumulative increase of over 50 times this year [3]. - A research team from the University of California, Davis, developed a brain-machine interface that could help individuals with speech loss due to neurological diseases regain their ability to "speak" [3]. - Researchers have created a neuromorphic computer that mimics the human brain structure, potentially operating 250,000 to 1,000,000 times faster than a biological brain while consuming only 10 kilowatts of power [3]. - China has successfully conducted its first prospective clinical trial for invasive brain-machine interfaces, becoming the second country after the US to enter this stage [3]. Institutional Insights - The advancement of invasive brain-machine interface technology in China is expected to drive rapid growth in related industries, including high-end imaging equipment, surgical robots, and AI medical applications, benefiting leading companies in these sectors [4]. - The potential of neuromorphic computing could revolutionize fields such as AI, robotics, and healthcare, with applications in smart medical devices and autonomous vehicles [4]. - The brain-machine interface industry is witnessing breakthroughs in applications for movement recovery, communication, and hearing restoration, supported by favorable national policies [5].